⌘K

Home/Filings/4/0001062993-21-002782

4//SEC Filing

Brown Robert Busard 4

Accession 0001062993-21-002782

CIK 0000819050other

View on SEC.gov Company Profile

Filed

Mar 16, 8:00 PM ET

Accepted

Mar 17, 4:21 PM ET

Size

5.9 KB

Accession

0001062993-21-002782

Insider Transaction Report

Form 4

Period: 2021-03-15

Brickell Biotech, Inc.BBI

Brown Robert Busard

Chief Executive Officer

Transactions

Purchase
Common Stock
2021-03-15$1.18/sh+100,000$117,780→ 186,957 total

Holdings

Common Stock
(indirect: By Trust)
64,851
Common Stock
(indirect: By Trust)
64,851

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Brickell Biotech, Inc.

CIK 0000819050

Entity typeother

Related Parties

1

filerCIK 0001782344

Filing Metadata

Form type: 4
Filed: Mar 16, 8:00 PM ET
Accepted: Mar 17, 4:21 PM ET
Size: 5.9 KB

View on SEC.gov